Toshihiro Nakashima

City:

Kikuchi

Country:

Japan

Published Applications:

Last publication date:

2019-03-14

Top Assignees for applications by Toshihiro Nakashima

The entities that hold a legal rights for patent applications filed by inventor Nakashima Toshihiro:

JURIDICAL FOUNDATION THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE 3 Kumamoto-shi, Japan
KOWA COMPANY, LTD. 2 Nagoya-shi, Japan
JURIDICAL FDN THE CHEMO-SERO-THERAPEUTIC RES INST 2 Kumamoto-shi, Japan
Juridical Foundation the Chemo-Sero-Therapeutic Research Institute 1 Kumamoto-ken, Japan
Juridical Foundation The Chem-Sero-Therapeutic Research Institute 1 Kumamoto-shi, Japan
Kowa Company, Ltd. 1 Aichi-ken, Japan
Juridical Foundation The Chemo-Sero-Therapeuric Research Institute 1 Kumamoto-shi, Japan
ASTELLAS PHARMA INC. 1 Tokyo, Japan
THE CHEMO-SERO-THERAPEUTIC RESERACH INSTITUTE 1 Kumamoto, Japan
THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE 1 Kumamoto, Japan
KM Biologics Co., Ltd. 1 Kumamoto, Japan

Recent patent applications by Nakashima Toshihiro

Toshihiro Nakashima from Kikuchi, JP has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-03-14

US20190077858A1

Chemistry; metallurgy

Human antibody against IL-18

#2 | 2018-05-03

US20180118813A1

Chemistry; metallurgy

Method for improving antibody

#3 | 2011-03-10

US20110059077A1

Chemistry; metallurgy

Humanized anti-human α9-integrin antibody

#4 | 2010-10-21

US20100267816A1

Physics

Human anti-amyloid beta peptide antibody and fragment of said antibody

#5 | 2010-07-01

US20100166793A1

Chemistry; metallurgy

Protease-resistant modified SEB and vaccine containing the same

#6 | 2008-06-12

US20080138860A1

Chemistry; metallurgy

Method for improving antibody

#7 | 2008-06-05

US20080131422A1

Physics

Human anti-amyloid β peptide antibody and fragment of said antibody

#8 | 2007-07-19

US20070166331A1

Human necessities

Modified SEB and prophylactics/remedies for immunopathy containing the same

InventorID:

6192589 ⎘